<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id><journal-title>BMC Medical Genetics</journal-title><issn pub-type="epub">1471-2350</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2350-5-22</article-id><article-id pub-id-type="pmid">15345028</article-id><article-id pub-id-type="doi">10.1186/1471-2350-5-22</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>TM4SF10 gene sequencing in XLMR patients identifies common polymorphisms but no disease-associated mutation</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Christophe-Hobertus</surname><given-names>Christiane</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>chobertu@ulb.ac.be</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Kooy</surname><given-names>Frank</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>Frank.Kooy@ua.ac.be</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Gecz</surname><given-names>Jozef</given-names></name><xref ref-type="aff" rid="I3">3</xref><xref ref-type="aff" rid="I4">4</xref><email>jozef.gecz@adelaide.edu.au</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Abramowicz</surname><given-names>Marc J</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>marcabra@ulb.ac.be</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Holinski-Feder</surname><given-names>Elke</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>Holinski-Feder@mgz-muenchen.de</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Schwartz</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="I7">7</xref><email>ceschwartz@ggc.org</email></contrib><contrib id="A7" corresp="yes" contrib-type="author"><name><surname>Christophe</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>dchristo@ulb.ac.be</email></contrib></contrib-group><aff id="I1"><label>1</label>Institut de Recherche Interdisciplinaire en Biologie Humaine et Mol&#x000e9;culaire (IRIBHM), Universit&#x000e9; Libre de Bruxelles, IBMM, B-6041 Gosselies, Belgium</aff><aff id="I2"><label>2</label>Department of Medical Genetics, University of Antwerp, Antwerp, Belgium</aff><aff id="I3"><label>3</label>Department of Genetic Medicine, Women's and Children's Hospital, Adelaide, Australia</aff><aff id="I4"><label>4</label>Department of Pediatrics, The University of Adelaide, Australia</aff><aff id="I5"><label>5</label>Service de G&#x000e9;n&#x000e9;tique M&#x000e9;dicale, H&#x000f4;pital Erasme, B-1070 Bruxelles, Belgium</aff><aff id="I6"><label>6</label>Medizinisch Genetisches Zentrum, Bayerstrasse 53, D-80335, Munchen, Germany</aff><aff id="I7"><label>7</label>Center for Molecular Studies, J.C. Self Research Institute, Greenwood, S.C. 29646, USA</aff><pub-date pub-type="collection"><year>2004</year></pub-date><pub-date pub-type="epub"><day>2</day><month>9</month><year>2004</year></pub-date><volume>5</volume><fpage>22</fpage><lpage>22</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/5/22"/><history><date date-type="received"><day>6</day><month>5</month><year>2004</year></date><date date-type="accepted"><day>2</day><month>9</month><year>2004</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2004 Christophe-Hobertus et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2004</copyright-year><copyright-holder>Christophe-Hobertus et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Christophe-Hobertus Christiane chobertu@ulb.ac.be </dc:author><dc:title> TM4SF10 gene sequencing in XLMR patients identifies common polymorphisms but no disease-associated mutation </dc:title><dc:date>2004</dc:date><dcterms:bibliographicCitation>BMC Medical Genetics 5(1): 22-. (2004)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2350(2004)5:1&#x0003c;22&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2350</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>The TM4SF10 gene encodes a putative four-transmembrane domains protein of unknown function termed Brain Cell Membrane Protein 1 (BCMP1), and is abundantly expressed in the brain. This gene is located on the short arm of human chromosome X at p21.1. The hypothesis that mutations in the TM4SF10 gene are associated with impaired brain function was investigated by sequencing the gene in individuals with hereditary X-linked mental retardation (XLMR).</p></sec><sec sec-type="methods"><title>Methods</title><p>The coding region (543 bp) of TM4SF10, including intronic junctions, and the long 3' untranslated region (3 233 bp), that has been conserved during evolution, were sequenced in 16 male XLMR patients from 14 unrelated families with definite, or suggestive, linkage to the TM4SF10 gene locus, and in 5 normal males.</p></sec><sec><title>Results</title><p>Five sequence changes were identified but none was found to be associated with the disease. Two of these changes correspond to previously known SNPs, while three other were novel SNPs in the TM4SF10 gene.</p></sec><sec><title>Conclusion</title><p>We have investigated the majority of the known MRX families linked to the TM4SF10 gene region. In the absence of mutations detected, our study indicates that alterations of TM4SF10 are not a frequent cause of XLMR.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Brain Cell Membrane Protein 1 (BCMP1) cDNA was fortuitously isolated from a thyroid cDNA library [<xref ref-type="bibr" rid="B1">1</xref>]. It encodes a 181aa-long putative four-transmembrane domain protein which appears related to both Peripheral Myelin Protein 22 / Epithelial Membrane Proteins and Claudins protein families, and exhibits significant similarities to the <italic>Caenorhabditis elegans </italic>VAB-9 protein, a protein that has recently been shown to be involved in the control of cell adhesion and epidermal morphology [<xref ref-type="bibr" rid="B2">2</xref>]. The protein sequence itself has been extremely well conserved during evolution, as exemplified by the observation that human and canine sequences are identical and differ from the mouse sequence at only 2 positions. The corresponding gene has now been renamed TM4SF10 in man and mouse, and is located on the X chromosome in both species, as well as in the other mammalian species investigated to date [<xref ref-type="bibr" rid="B1">1</xref>].</p><p>Initial Northern blot analysis of TM4SF10/BCMP1 gene transcripts distribution in adult dog tissues revealed very high expression in the brain, and lower but clearly detectable levels of expression in most of the tissues examined [<xref ref-type="bibr" rid="B1">1</xref>]. Data mining in the SAGEmap database [<xref ref-type="bibr" rid="B3">3</xref>] confirmed this observation in man, as elevated tag counts have been reported in brain astrocytoma (SAGE H127 library), brain ependymoma (SAGE ependymoma 353 and 582 libraries) and normal spinal cord (SAGE normal spinal cord library) as compared to other tissues. Together with its localization on the X chromosome, the high expression level detected in the brain and the putative role of the encoded protein in specific cell contacts raised the possibility that the TM4SF10 gene may be involved in X-linked mental retardation (XLMR) in man.</p><p>Initially, the TM4SF10 gene was assigned to Xp11.4 [<xref ref-type="bibr" rid="B1">1</xref>]. As the integration between human cytogenetic and DNA sequence-based maps is still evolving, the gene has been reassigned to band p21.1. It is noteworthy that TM4SF2, another gene encoding a four-transmembrane domain protein, is located at the p11.4-p21.1 border on human chromosome X, in the very close vicinity of TM4SF10, and constitutes a known XLMR gene [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Recent compilations of XLMR families [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>] mention several conditions mapped to the Xp11.4-p21.1 region. We report the result of mutation screening of TM4SF10 in a cohort of XLMR patients whose gene was mapped to this region of the X chromosome and does not correspond to TM4SF2.</p></sec><sec sec-type="methods"><title>Methods</title><p>Blood genomic DNA was collected from 16 patients (14 unrelated) and 5 unrelated healthy volunteers using a standard procedure [<xref ref-type="bibr" rid="B9">9</xref>]. The patients were affected males from families with definite, or possible, linkage to the region at Xp11.4-p21.1. Patients belonged to the following published MRX(S) families: MRX9 [<xref ref-type="bibr" rid="B10">10</xref>], MRX10 [<xref ref-type="bibr" rid="B11">11</xref>], MRX11 [<xref ref-type="bibr" rid="B11">11</xref>], MRX12 [<xref ref-type="bibr" rid="B11">11</xref>], MRX18 [<xref ref-type="bibr" rid="B12">12</xref>], MRX56 [<xref ref-type="bibr" rid="B6">6</xref>] and MRXS10 [<xref ref-type="bibr" rid="B13">13</xref>]. Additional patients were from an XLMR family with epilepsy [<xref ref-type="bibr" rid="B14">14</xref>] and 4 other XLMR families (C.S., F.K., J.G., unpublished), a MRXS family with macrocephaly and large ears (C.S., unpublished), and another MRXS family (J.G., unpublished). Chromosomal linkage data and major phenotypic traits are described in table <xref ref-type="table" rid="T1">1</xref>. All samples were studied anonymously and all procedures met the standards of our institutional ethics committee.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Description of the patients included in the study</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Patient</td><td align="center">Family</td><td align="center">Linkage data</td><td align="left">Phenotype</td></tr></thead><tbody><tr><td align="center">P1, P2</td><td align="center">XLMR family (F.K., now MRX79)</td><td align="center">chromosome X</td><td align="left">X-linked mental retardation</td></tr><tr><td align="center">P3, P4</td><td align="center">MRXS10</td><td align="center">Xp11.21-Xp11.4</td><td align="left">Mental retardation, choreoathetosis, abnormal behavior</td></tr><tr><td align="center">P5</td><td align="center">XLMR family (F.K.)</td><td align="center">Chromosome X, pericentromeric</td><td align="left">Non-syndromic mental retardation</td></tr><tr><td align="center">P6</td><td align="center">MRX9</td><td align="center">Xp11.22-Xp11.4</td><td align="left">Non-syndromic mental retardation</td></tr><tr><td align="center">P7</td><td align="center">MRX10</td><td align="center">Xp11.3-Xp21.2</td><td align="left">Non-syndromic mental retardation</td></tr><tr><td align="center">P8</td><td align="center">MRX11</td><td align="center">Xp11.3-Xp21.2</td><td align="left">Non-syndromic mental retardation</td></tr><tr><td align="center">P9</td><td align="center">MRX12</td><td align="center">Xp11.21-Xp21.2</td><td align="left">Non-syndromic mental retardation</td></tr><tr><td align="center">P10</td><td align="center">MRX18</td><td align="center">Xp11.3-Xp21.2</td><td align="left">Non-syndromic mental retardation</td></tr><tr><td align="center">P11</td><td align="center">XLMR family with epilepsy</td><td align="center">Xp11.23-Xp22.22</td><td align="left">Non-syndromic mental retardation, epilepsy</td></tr><tr><td align="center">P12</td><td align="center">MRXS family (J.G.)</td><td align="center">Xp21.3-Xq21.3</td><td align="left">Non-syndromic mental retardation</td></tr><tr><td align="center">P13</td><td align="center">XLMR family with macrocephaly (J.G.)</td><td align="center">Xp11.4-Xq13.1</td><td align="left">Macrocephaly, moderate to profound mental retardation</td></tr><tr><td align="center">P14</td><td align="center">XLMR family (C.S.)</td><td align="center">Xp11.3-Xp21.1</td><td align="left">Seizures, ataxia, aggressive and hyperactive behavior, speech delay, mild to moderate mental retardation</td></tr><tr><td align="center">P15</td><td align="center">MRXS (C.S.)</td><td align="center">Xp22.22-Xq24</td><td align="left">Macrocephaly, prominent ears and moderate to severe mental retardation</td></tr><tr><td align="center">P16</td><td align="center">MRX56</td><td align="center">Xp11.21-Xp21.1</td><td align="left">Non-syndromic mental retardation</td></tr></tbody></table></table-wrap><p>PCR reactions were performed in a final volume of 100 &#x003bc;l containing 200 ng of genomic DNA, 1 &#x003bc;g of each primer (see table <xref ref-type="table" rid="T2">2</xref> for primer sequences), 200 &#x003bc;M of each dNTP, 1X PCR buffer (QIAGEN) and 2.5 units of Taq polymerase (QIAGEN). Additionally, 10% DMSO or 20% Q solution (QIAGEN) were also included in some reactions (see table <xref ref-type="table" rid="T2">2</xref>). After an initial denaturation step (93&#x000b0;C, 45 sec.), 35 cycles were conducted as follows: 93&#x000b0;C, 45 sec.; annealing temp. (see table <xref ref-type="table" rid="T2">2</xref>), 45 sec.; 72&#x000b0;C, 45 sec. (amplicons Ex1&#x02013;Ex3) or 1 min. (amplicons 3'UTR F1&#x02013;F4). A final extension step (72&#x000b0;C, 3 min.) was done at the end of the reaction. PCR products were purified using the QIAquick PCR purification kit (QIAGEN) before sequencing. Purified PCR fragments were roughly quantitated by agarose gel electrophoresis using SmartLadder molecular weight marker (EUROGENTEC) as a quantitative reference.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>PCR conditions and primer sequences used to amplify TM4SF10 gene fragments from total genomic DNA</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Amplicon</td><td align="left">Size</td><td align="left">Primer sequence</td><td align="left">PCR conditions</td></tr></thead><tbody><tr><td align="left">Ex1</td><td align="left">442 bp</td><td align="left">fw: AGAGCCCCGAGGGAGCGA, rev: GGGGACAGGCGGTGACTG</td><td align="left">T<sub>anneal </sub>= 55&#x000b0;C, 10% DMSO</td></tr><tr><td align="left">Ex2</td><td align="left">447 bp</td><td align="left">fw: AAATCCTAGCAAACCCCTGG, rev: TCTGCATAGGAAAGGAAGATGG</td><td align="left">T<sub>anneal </sub>= 50&#x000b0;C</td></tr><tr><td align="left">Ex3</td><td align="left">447 bp</td><td align="left">fw: CCATCTAGAACAAGCCATCTTTAA, rev: TAAATCAACTGAGCAAACTGCTTG</td><td align="left">T<sub>anneal </sub>= 50&#x000b0;C</td></tr><tr><td align="left">3'UTR F1</td><td align="left">959 bp</td><td align="left">fw: GGCCTGGGGTGCAACTATAT, rev: TAGGCAAATGTATGTGGAGGGT</td><td align="left">T<sub>anneal </sub>= 55&#x000b0;C, 10% DMSO</td></tr><tr><td align="left">3'UTR F2</td><td align="left">1101 bp</td><td align="left">fw: ATTGGTGCCTCAGCCCTATCTA, rev: GCAACCATTCTTAAGACAAGCT</td><td align="left">T<sub>anneal </sub>= 57&#x000b0;C, 20% Q solution</td></tr><tr><td align="left">3'UTR F3</td><td align="left">1130 bp</td><td align="left">fw : CAGTATGTTCTGGTTTTGGCCC, rev : TATCTAACAATGGGTTTGTGGC</td><td align="left">T<sub>anneal </sub>= 57&#x000b0;C, 20% Q solution</td></tr><tr><td align="left">3'UTR F4</td><td align="left">1097 bp</td><td align="left">fw : CCTTCTCAGCAAAGAGCCCTAC, rev : AAGGATCTTGGGAGATAATTTG</td><td align="left">T<sub>anneal </sub>= 57&#x000b0;C, 20% Q solution</td></tr></tbody></table></table-wrap><p>About 50&#x02013;100 ng of purified PCR fragment was used in a DNA sequencing reaction using a nested, internal primer. DNA sequencing was performed using ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction kit (Applied Biosystems) on an Applied Biosystems 3100 automatic DNA sequencer. The sequences of the primers are given in table <xref ref-type="table" rid="T3">3</xref>.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Sequences of the primers used for sequencing of TM4SF10 gene fragments</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Amplicon</td><td align="left">Primer sequence</td></tr></thead><tbody><tr><td align="left">Ex1</td><td align="left">fw: CCGAGGGAGCGAGTCCCC</td></tr><tr><td align="left">Ex2</td><td align="left">fw: CACATCTGTTGAGCCACTGC</td></tr><tr><td align="left">Ex3</td><td align="left">rev: GATGCTCCACAAGTGTTTTAGA</td></tr><tr><td align="left">3'UTR F1</td><td align="left">fw : TGCCTGAACCCTAAGAACTATG, rev : GGAGGGTTAGGGAACAACTTAT</td></tr><tr><td align="left">3'UTR F2</td><td align="left">fw : CTGCATGAGTTGCTTTTGTACC, rev : GCAACCATTCTTAAGACAAGCT</td></tr><tr><td align="left">3'UTR F3</td><td align="left">fw : TCTGTTAAGAGCAGGACCACAT, rev1: ACTCGAGATGTGATGATATTGG, rev2 : TATCTAACAATGGGTTTGTGGC</td></tr><tr><td align="left">3'UTR F4</td><td align="left">fw : AACATGAAAATTGTTGCTTCTC, rev : AAGGATCTTGGGAGATAATTTG</td></tr></tbody></table></table-wrap></sec><sec><title>Results and discussion</title><sec><title>Sequencing of TM4SF10 coding region</title><p>The human TM4SF10 gene is composed of 3 exons and produces a 4 kb-long mRNA. The short coding region (543 bp) is interrupted by 2 introns and the last and the largest exon also contains a 3 233 bp-long 3'UTR (see Figure <xref ref-type="fig" rid="F1">1</xref>). Initially, we sequenced the coding region and exon-intron junctions of the gene in the DNAs from 16 XLMR patients and from one normal male (amplicons Ex1&#x02013;Ex3, Figure <xref ref-type="fig" rid="F1">1</xref>). No mutations were identified. One silent polymorphism was observed at position 186 in the cDNA sequence (clone DKFZp761J17121; GenBank accession number AL136550), corresponding to the 3<sup>rd </sup>base of the codon Arg59, where a C residue was present in half of the sequences and a G residue in the other half. Individual single nucleotide polymorphism (SNP) data are shown in table <xref ref-type="table" rid="T4">4</xref>. It is noteworthy that patients P3 and P4 who belong to the same family exhibit a difference in their TM4SF10 gene sequence at this level. This observation argues against a causal role of the gene in this family. The 186C&#x0003e;G polymorphism in the TM4SF10 gene had been previously reported [<xref ref-type="bibr" rid="B15">15</xref>].</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Schematic of the TM4SF10 gene and single nucleotide polymorphisms identified in the study. </bold>The structure of the gene is outlined with exons represented as light-blue boxes and the coding region as dark-blue areas within the boxes. The 3' end of the gene is also enlarged (bottom). Amplified regions are delineated and locations of sequence primers (arrows) used in this study are depicted. Identified SNPs are indicated (dotted lines) with reference to genomic contig (GenBank accession number NT_011757) sequence coordinates and cDNA (clone DKFZp761J17121; GenBank accession numberAL136550) sequence coordinates (italics) when relevant. Numbers in parentheses indicate the occurrences of the nucleotide in the individual sequences. The 3 novel SNPs identified in the work appear in red.</p></caption><graphic xlink:href="1471-2350-5-22-1"/></fig><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Description of the individual TM4SF10 gene SNP haplotypes determined in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">Exon 1: 186 (Arg59), [21589434]</td><td align="center">3' UTR: 705, [21562747]</td><td align="center">3' UTR: 2870, [21560583]</td><td align="center">3' UTR: 2907, [21560546]</td><td align="center">3' intergenic: [21559611]</td></tr></thead><tbody><tr><td align="left">N1</td><td align="center">C</td><td align="center">C</td><td align="center">G</td><td align="center">T</td><td align="center">C</td></tr><tr><td align="left">N2</td><td align="center">(n.d.)</td><td align="center">C</td><td align="center">C</td><td align="center">C</td><td align="center">C</td></tr><tr><td align="left">N3</td><td align="center">(n.d.)</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">C</td></tr><tr><td align="left">N4</td><td align="center">(n.d.)</td><td align="center">T</td><td align="center">C</td><td align="center">T</td><td align="center">T</td></tr><tr><td align="left">N5</td><td align="center">(n.d.)</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">C</td></tr><tr><td align="left">P1</td><td align="center">C</td><td align="center">T</td><td align="center">C</td><td align="center">T</td><td align="center">T</td></tr><tr><td align="left">P2</td><td align="center">C</td><td align="center">T</td><td align="center">C</td><td align="center">T</td><td align="center">T</td></tr><tr><td align="left">P3</td><td align="center">G</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">C</td></tr><tr><td align="left">P4</td><td align="center">C</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">C</td></tr><tr><td align="left">P5</td><td align="center">G</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">T</td></tr><tr><td align="left">P6</td><td align="center">G</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">T</td></tr><tr><td align="left">P7</td><td align="center">G</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">C</td></tr><tr><td align="left">P8</td><td align="center">G</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">C</td></tr><tr><td align="left">P9</td><td align="center">G</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">C</td></tr><tr><td align="left">P10</td><td align="center">C</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">T</td></tr><tr><td align="left">P11</td><td align="center">C</td><td align="center">T</td><td align="center">C</td><td align="center">T</td><td align="center">T</td></tr><tr><td align="left">P12</td><td align="center">G</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">C</td></tr><tr><td align="left">P13</td><td align="center">G</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">C</td></tr><tr><td align="left">P14</td><td align="center">C</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">T</td></tr><tr><td align="left">P15</td><td align="center">C</td><td align="center">T</td><td align="center">C</td><td align="center">T</td><td align="center">T</td></tr><tr><td align="left">P16</td><td align="center">G</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">C</td></tr></tbody></table><table-wrap-foot><p>The first row identifies the source of the DNA, either a normal individual (Nx) or a patient (Px; see also table 1 for the detailed description of the patients). The individual bases found at each polymorphic position in the DNA sequence (identified by the nucleotide position in the cDNA sequence and/or in the genomic contig sequence [in square brackets]; see also figure 1) are given in the following rows. (n.d.): not determined.</p></table-wrap-foot></table-wrap></sec><sec><title>Sequencing of the 3'UTR</title><p>The long 3'UTR sequence of the TM4SF10/BCMP1 transcript is highly conserved, with an overall score of 72% when human, dog, mouse and rat sequences are compared. As the 3'UTR of mRNAs may contain regulatory sequences that participate in the control of gene expression, we decided to screen this part of the gene as well. The entire region, including the sequences around the polyadenylation site, was subdivided into four overlapping fragments of approximately 1 kb in length (3'UTR F1&#x02013;F4, Figure <xref ref-type="fig" rid="F1">1</xref>) and sequenced from both ends. In fragment 3' UTR F3 the presence of a stretch of 12 consecutive A residues on the sense strand resulted in difficulties in proper reading of the sequences located downstream of this motif. In order to overcome this problem, an additional sequence primer (rev2) was used to obtain overlaps between the 3 separate sequences for each individual fragment. In the cDNA sequence AL136550 the motif is composed of 13 A residues, which is a likely sequence artefact.</p><p>TM4SF10 sequence was obtained from 16 patients and 5 controls. Four SNPs were identified in the non-coding part of the gene: 3 of them were located in the 3'UTR of the mRNA while the fourth one was located downstream of the polyadenylation site (Figure <xref ref-type="fig" rid="F1">1</xref>). Only this last one (C21559611T) had been previously reported in the SNP database [<xref ref-type="bibr" rid="B15">15</xref>], the other three representing novel SNPs in the TM4SF10 gene. The individual SNP haplotypes determined here are described in table <xref ref-type="table" rid="T4">4</xref>. It is also noteworthy that during the course of our investigation, the genetic defect of one of the unpublished XLMR family included in the study (see top of table <xref ref-type="table" rid="T1">1</xref>) has been identified and mapped to Xq28, within the MECP2 gene [<xref ref-type="bibr" rid="B16">16</xref>].</p></sec></sec><sec><title>Conclusions</title><p>In this study, we have investigated the majority of the known MRX families linked to the TM4SF10 gene region. In the absence of mutations detected, our results indicate that alterations in the transcribed region of TM4SF10 are not a frequent cause of XLMR. Although the gene promoter has not been identified and screened yet, it appears very unlikely that all mutations would be there.</p><p>This work also identified three novel SNPs in the TM4SF10 gene, which adds to our knowledge of SNP occurrence within this gene.</p></sec><sec><title>Competing interests</title><p>None declared.</p></sec><sec><title>Authors' contributions</title><p>CCH performed/managed the PCR and sequencing reactions, and analyzed the DNA sequences. FK, JG, MJA, EHF and CS provided the DNA samples. These authors also participated in the writing of the manuscript. DC conceived and supervised the study, and drafted the manuscript. All authors read and approved the final manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/5/22/prepub"/></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank G. Hoganson for providing material on his MRXS family. We also thank Nathalie Celio and Fran&#x000e7;ois Gensale for expert technical assistance. This work was supported by the Belgian program "P&#x000f4;les d'Attraction Interuniversitaires" (PAI, Prime Minister's Office, Science Policy Programming) and the Fonds National de la Recherche Scientifique (FNRS-FRSM, Belgium). C.S. is supported by NIH grant HD26202. D.C. is a research director of the Belgian FNRS.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christophe-Hobertus</surname><given-names>C</given-names></name><name><surname>Szpirer</surname><given-names>C</given-names></name><name><surname>Guyon</surname><given-names>R</given-names></name><name><surname>Christophe</surname><given-names>D</given-names></name></person-group><article-title>Identification of the gene encoding Brain Cell Membrane Protein 1 (BCMP1), a putative four-transmembrane protein distantly related to the Peripheral Myelin Protein 22 / Epithelial Membrane Proteins and the Claudins</article-title><source>BMC Genomics</source><year>2001</year><volume>2</volume><fpage>3</fpage><pub-id pub-id-type="pmid">11472633</pub-id><pub-id pub-id-type="doi">10.1186/1471-2164-2-3</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simske</surname><given-names>JS</given-names></name><name><surname>K&#x000f6;ppen</surname><given-names>M</given-names></name><name><surname>Sims</surname><given-names>P</given-names></name><name><surname>Hodgkin</surname><given-names>J</given-names></name><name><surname>Yonkof</surname><given-names>A</given-names></name><name><surname>Hardin</surname><given-names>J</given-names></name></person-group><article-title>The cell junction protein VAB-9 regulates adhesion and epidermal morphology in C. elegans</article-title><source>Nature Cell Biol</source><year>2003</year><volume>5</volume><fpage>619</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">12819787</pub-id><pub-id pub-id-type="doi">10.1038/ncb1002</pub-id></citation></ref><ref id="B3"><citation citation-type="other"><article-title>SAGEmap</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SAGE/"/></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zemni</surname><given-names>R</given-names></name><name><surname>Bienvenu</surname><given-names>T</given-names></name><name><surname>Vinet</surname><given-names>MC</given-names></name><name><surname>Sefiani</surname><given-names>A</given-names></name><name><surname>Carri&#x000e9;</surname><given-names>A</given-names></name><name><surname>Billuart</surname><given-names>P</given-names></name><name><surname>McDonell</surname><given-names>N</given-names></name><name><surname>Couvert</surname><given-names>P</given-names></name><name><surname>Francis</surname><given-names>F</given-names></name><name><surname>Chafey</surname><given-names>P</given-names></name><name><surname>Fauchereau</surname><given-names>F</given-names></name><name><surname>Friocourt</surname><given-names>G</given-names></name><name><surname>des Portes</surname><given-names>V</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name><name><surname>Frints</surname><given-names>S</given-names></name><name><surname>Meindl</surname><given-names>A</given-names></name><name><surname>Brandau</surname><given-names>O</given-names></name><name><surname>Ronce</surname><given-names>N</given-names></name><name><surname>Moraine</surname><given-names>C</given-names></name><name><surname>van Bokhoven</surname><given-names>H</given-names></name><name><surname>Ropers</surname><given-names>HH</given-names></name><name><surname>Sudbrak</surname><given-names>R</given-names></name><name><surname>Kahn</surname><given-names>A</given-names></name><name><surname>Fryns</surname><given-names>JP</given-names></name><name><surname>Beldjord</surname><given-names>C</given-names></name><name><surname>Chelly</surname><given-names>J</given-names></name></person-group><article-title>A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation</article-title><source>Nature Genet</source><year>2000</year><volume>24</volume><fpage>167</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">10655063</pub-id><pub-id pub-id-type="doi">10.1038/72829</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abidi</surname><given-names>FE</given-names></name><name><surname>Holinski-Feder</surname><given-names>E</given-names></name><name><surname>Rittinger</surname><given-names>O</given-names></name><name><surname>Kooy</surname><given-names>F</given-names></name><name><surname>Lubs</surname><given-names>HA</given-names></name><name><surname>Stevenson</surname><given-names>RE</given-names></name><name><surname>Schwartz</surname><given-names>CE</given-names></name></person-group><article-title>A novel 2 bp deletion in the TM4SF2 gene is associated with MRX58</article-title><source>J Med Genet</source><year>2002</year><volume>39</volume><fpage>430</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">12070254</pub-id><pub-id pub-id-type="doi">10.1136/jmg.39.6.430</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiurazzi</surname><given-names>P</given-names></name><name><surname>Hamel</surname><given-names>BCJ</given-names></name><name><surname>Neri</surname><given-names>G</given-names></name></person-group><article-title>XLMR genes: update 2000</article-title><source>Eur J Hum Genet</source><year>2001</year><volume>9</volume><fpage>71</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">11313739</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chelly</surname><given-names>J</given-names></name><name><surname>Mandel</surname><given-names>J-L</given-names></name></person-group><article-title>Monogenic causes of X-linked mental retardation</article-title><source>Nat Rev Genet</source><year>2001</year><volume>2</volume><fpage>669</fpage><lpage>679</lpage><pub-id pub-id-type="pmid">11533716</pub-id><pub-id pub-id-type="doi">10.1038/35088558</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ropers</surname><given-names>H-H</given-names></name><name><surname>Hoeltzenbein</surname><given-names>M</given-names></name><name><surname>Kaalscheuer</surname><given-names>V</given-names></name><name><surname>Yntema</surname><given-names>H</given-names></name><name><surname>Hamel</surname><given-names>B</given-names></name><name><surname>Fryns</surname><given-names>J-P</given-names></name><name><surname>Chelly</surname><given-names>J</given-names></name><name><surname>Partington</surname><given-names>M</given-names></name><name><surname>Gecz</surname><given-names>J</given-names></name><name><surname>Moraine</surname><given-names>C</given-names></name></person-group><article-title>Nonsyndromic X-linked mental retardation: where are the missing mutations?</article-title><source>Trends Genet</source><year>2003</year><volume>19</volume><fpage>316</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">12801724</pub-id><pub-id pub-id-type="doi">10.1016/S0168-9525(03)00113-6</pub-id></citation></ref><ref id="B9"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Sambrook</surname><given-names>J</given-names></name><name><surname>Russell</surname><given-names>DW</given-names></name></person-group><source>Molecular Cloning: A Laboratory Manual</source><year>2001</year><edition>3</edition><publisher-name>Cold Spring Harbor, Cold Spring Harbor Laboratory Press</publisher-name></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winnepenninckx</surname><given-names>B</given-names></name><name><surname>Errijgers</surname><given-names>V</given-names></name><name><surname>Reyniers</surname><given-names>E</given-names></name><name><surname>De Deyn</surname><given-names>PP</given-names></name><name><surname>Abidi</surname><given-names>FE</given-names></name><name><surname>Schwartz</surname><given-names>CE</given-names></name><name><surname>Kooy</surname><given-names>RF</given-names></name></person-group><article-title>Family MRX9 revisited: further evidence for locus heterogeneity in MRX</article-title><source>Am J Med Genet</source><year>2002</year><volume>112</volume><fpage>17</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">12239714</pub-id><pub-id pub-id-type="doi">10.1002/ajmg.10663</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>B</given-names></name><name><surname>Gedeon</surname><given-names>A</given-names></name><name><surname>Mulley</surname><given-names>J</given-names></name><name><surname>Turner</surname><given-names>G</given-names></name></person-group><article-title>Localization of non-specific X-linked mental retardation genes</article-title><source>Am J Med Genet</source><year>1992</year><volume>43</volume><fpage>392</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">1605217</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gedeon</surname><given-names>A</given-names></name><name><surname>Kerr</surname><given-names>B</given-names></name><name><surname>Mulley</surname><given-names>J</given-names></name><name><surname>Turner</surname><given-names>G</given-names></name></person-group><article-title>Pericentromeric genes for non-specific X-linked mental retardation (MRX)</article-title><source>Am J Med Genet</source><year>1994</year><volume>51</volume><fpage>553</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">7943039</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reyniers</surname><given-names>E</given-names></name><name><surname>Van Bogaert</surname><given-names>P</given-names></name><name><surname>Peeters</surname><given-names>N</given-names></name><name><surname>Vits</surname><given-names>L</given-names></name><name><surname>Pauly</surname><given-names>F</given-names></name><name><surname>Fransen</surname><given-names>E</given-names></name><name><surname>Van Regemorter</surname><given-names>N</given-names></name><name><surname>Kooy</surname><given-names>RF</given-names></name></person-group><article-title>A new neurological syndrome with mental retardation, choreoathetosis, and abnormal behavior maps to chromosome Xp11</article-title><source>Am J Hum Genet</source><year>1999</year><volume>65</volume><fpage>1406</fpage><lpage>1412</lpage><pub-id pub-id-type="pmid">10521307</pub-id><pub-id pub-id-type="doi">10.1086/302638</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hedera</surname><given-names>P</given-names></name><name><surname>Alvarado</surname><given-names>D</given-names></name><name><surname>Beydoun</surname><given-names>A</given-names></name><name><surname>Fink</surname><given-names>JK</given-names></name></person-group><article-title>Novel mental retardation-epilepsy syndrome linked to Xp21.1-p11.4</article-title><source>Ann Neurol</source><year>2002</year><volume>51</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">11782983</pub-id><pub-id pub-id-type="doi">10.1002/ana.10051</pub-id></citation></ref><ref id="B15"><citation citation-type="other"><article-title>Single Nucleotide Polymorphism</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/"/></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winnepenninckx</surname><given-names>B</given-names></name><name><surname>Errijgers</surname><given-names>V</given-names></name><name><surname>Hayez-Delatte</surname><given-names>F</given-names></name><name><surname>Reyniers</surname><given-names>E</given-names></name><name><surname>Kooy</surname><given-names>RF</given-names></name></person-group><article-title>Identification of a family with nonspecific mental retardation (MRX79) with the A140V mutation in the MECP2 gene: is there a need for routine screening?</article-title><source>Hum Mutat</source><year>2002</year><volume>20</volume><fpage>249</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">12325019</pub-id><pub-id pub-id-type="doi">10.1002/humu.10130</pub-id></citation></ref></ref-list></back></article> 